2023 -2024 Global Head of Legal, Biomedical Research (ad interim) @
2022 -2023 Global Head Ethics, Risk and Compliance, Speak Up @
2017 -2022 Vice President, Global Head Ethics, Risk and Compliance, Oncology @
2023 -2024 Board Member @
2014 -2017 General Counsel @
2011 -2014 Associate General Counsel Healthcare Compliance and Research @
2010 -2011 Director of Compliance, Healthcare Care Systems @
2009 -2010 Senior Counsel, Vital Signs Inc., a GEHC Company @
2008 -2009 Senior Corporate Counsel @
2007 -2008 Vice President @
2003 -2007 Senior Corporate Counsel @ Pfizer Inc.
2000 -2003 Associate @
1997 -2000 Associate @
Robert Ladd Education
University of North Carolina School of Law
JD (Executive Editor, International Law Journal)
1994-1997
North Carolina State University
Master's degree (English Language and Literature)
North Carolina State University
Bachelor of Arts - BA (Economics)
Robert Ladd Skills
Corporate Law
Litigation
Pharmaceutical Industry
Intellectual Property
Due Diligence
Commercial Litigation
Corporate Governance
Legal Writing
Licensing
Research
Medical Devices
Patents
Mergers & Acquisitions
Public Speaking
Strategic Planning
FCPA
Biotechnology
Privacy Law
Mergers
Contract Negotiation
Regulatory Affairs
FDA
Joint Ventures
Technology Transfer
Competition Law
Employment Law
Trademarks
Regulatory Requirements
Microsoft Word
Microsoft Excel
Sales
Mergers and Acquisitions
Robert Ladd Summary
Robert Ladd, based in New York, NY, US, is currently a Senior Vice President, Chief Ethics and Compliance Officer at Gilead Sciences. Robert Ladd brings experience from previous roles at Novartis and NOVARTIS US FOUNDATION. Robert Ladd holds a 1994 - 1997 JD in Executive Editor, International Law Journal @ University of North Carolina School of Law. With a robust skill set that includes Corporate Law, Litigation, Pharmaceutical Industry, Intellectual Property, Due Diligence and more. Robert Ladd has 3 emails and 4 mobile phone numbers on RocketReach.
Looking for a different Robert Ladd?
Find contact details for 700 million professionals.